| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |